Search

Your search keyword '"Nakano, Ryosuke"' showing total 180 results

Search Constraints

Start Over You searched for: Author "Nakano, Ryosuke" Remove constraint Author: "Nakano, Ryosuke" Search Limiters Full Text Remove constraint Search Limiters: Full Text
180 results on '"Nakano, Ryosuke"'

Search Results

9. Protocol to evaluate the efficacy and safety of tolvaptan in patients with refractory ascites after liver resection: an open-label, single-arm phase I/II study

10. CD4+ T cell-derived IL-22 enhances liver metastasis by promoting angiogenesis

11. Preoperative percutaneous or transvascular marking for curative resection of small liver tumours with potential for missing during hepatectomy: a study protocol for an open-label, single-arm phase II study

12. Efficacy and safety of lenvatinib–transcatheter arterial chemoembolisation sequential therapy followed by surgical resection for intermediate-stage hepatocellular carcinoma beyond Up-to-7 criteria: a study protocol for a multicentre, single-arm, prospective study

15. IL-22BP controls the progression of liver metastasis in colorectal cancer

16. Impact of a new liver immune status index among patients with hepatocellular carcinoma after initial hepatectomy

17. Adoptive immunotherapy with natural killer cells from peripheral blood CD34+stem cells to prevent hepatocellular carcinoma recurrence after curative hepatectomy: a study protocol for an open-label, single-arm phase I study

18. A methodology for creating mutants of G‐protein coupled receptors stabilized in active state by combining statistical thermodynamics and evolutionary molecular engineering

23. The Novel Hypoglycemic Agent YM440 Improves Hepatic Insulin Resistance in Obese Zucker Fatty Rats

28. Efficient heterologous expression in Aspergillus oryzae of a unique dye-decolorizing peroxidase, DyP, of Geotrichum candidum Dec 1

29. DAP12/TREM2 Expression by Mouse and Human Liver DC: Functional Implications and Regulation of Liver Ischemia-Reperfusion Injury

33. Disruption of Insulin Receptor Substrate 2 Causes Type 2 Diabetes Because of Liver Insulin Resistance and Lack of Compensatory β-Cell Hyperplasia

41. Novel anticarcinoembryonic antigen antibody–drug conjugate has antitumor activity in the existence of soluble antigen

42. Mixinging Prediction with Incoming Air and the Rocket Exhaust of the RBCC Engine under Scramjet Mode

43. Disruption of Insulin Receptor Substrate 2 Causes Type 2 Diabetes Because of Liver Insulin Resistance and Lack of Compensatory [Beta]-Cell Hyperplasia

44. IRS-2 Deficient Mice Developed Type 2 Diabetes Due to Insulin Resistance in Liver and Lack of Compensatory [Beta]-Cell Hyperplasia

45. Normalization of Hyperglycemia after Adenovirus-Mediated Gene Transfer of IRS-2 into IRS-2 Deficient Mice

47. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types

48. Nonfucosylated Therapeutic IgG1 Antibody Can Evade the Inhibitory Effect of Serum Immunoglobulin G on Antibody-Dependent Cellular Cytotoxicity through its High Binding to FcγRIIIa

Catalog

Books, media, physical & digital resources